Miniaturized therapeutic systems for ultrasound-modulated drug delivery to the central and peripheral nervous system
- PMID: 38442747
- PMCID: PMC11031353
- DOI: 10.1016/j.addr.2024.115275
Miniaturized therapeutic systems for ultrasound-modulated drug delivery to the central and peripheral nervous system
Abstract
Ultrasound is a promising technology to address challenges in drug delivery, including limited drug penetration across physiological barriers and ineffective targeting. Here we provide an overview of the significant advances made in recent years in overcoming technical and pharmacological barriers using ultrasound-assisted drug delivery to the central and peripheral nervous system. We commence by exploring the fundamental principles of ultrasound physics and its interaction with tissue. The mechanisms of ultrasonic-enhanced drug delivery are examined, as well as the relevant tissue barriers. We highlight drug transport through such tissue barriers utilizing insonation alone, in combination with ultrasound contrast agents (e.g., microbubbles), and through innovative particulate drug delivery systems. Furthermore, we review advances in systems and devices for providing therapeutic ultrasound, as their practicality and accessibility are crucial for clinical application.
Keywords: Cavitation; Implantable device; Microbubble; Sonochemistry; Sonosensitizer; Ultrasound transducer; Wearable device.
Copyright © 2024 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Ultrasound-Responsive Cavitation Nuclei for Therapy and Drug Delivery.Ultrasound Med Biol. 2020 Jun;46(6):1296-1325. doi: 10.1016/j.ultrasmedbio.2020.01.002. Epub 2020 Mar 10. Ultrasound Med Biol. 2020. PMID: 32165014 Free PMC article. Review.
-
Microbubble Agents: New Directions.Ultrasound Med Biol. 2020 Jun;46(6):1326-1343. doi: 10.1016/j.ultrasmedbio.2020.01.027. Epub 2020 Mar 11. Ultrasound Med Biol. 2020. PMID: 32169397 Review.
-
Ultrasound and microbubble mediated therapeutic delivery: Underlying mechanisms and future outlook.J Control Release. 2020 Oct 10;326:75-90. doi: 10.1016/j.jconrel.2020.06.008. Epub 2020 Jun 14. J Control Release. 2020. PMID: 32554041 Review.
-
Opening doors with ultrasound and microbubbles: Beating biological barriers to promote drug delivery.Adv Drug Deliv Rev. 2021 May;172:9-36. doi: 10.1016/j.addr.2021.02.015. Epub 2021 Mar 8. Adv Drug Deliv Rev. 2021. PMID: 33705877 Review.
-
Microbubbles as ultrasound contrast agents and in targeted drug delivery.Crit Rev Biomed Eng. 2008;36(4):225-55. doi: 10.1615/critrevbiomedeng.v36.i4.10. Crit Rev Biomed Eng. 2008. PMID: 19961426 Review.
Cited by
-
US/PA/MR multimodal imaging-guided multifunctional genetically engineered bio-targeted synergistic agent for tumor therapy.J Nanobiotechnology. 2024 Oct 10;22(1):615. doi: 10.1186/s12951-024-02868-9. J Nanobiotechnology. 2024. PMID: 39385196 Free PMC article.
References
-
- Wang JB, Di Ianni T, Vyas DB, Huang Z, Park S, Hosseini-Nassab N, Aryal M, Airan RD, Focused Ultrasound for Noninvasive, Focal Pharmacologic Neurointervention, Front. Neurosci 14 (2020). https://www.frontiersin.org/articles/10.3389/fnins.2020.00675 (accessed November 17, 2023). - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources